EBS (Emergent Corp) Bathi resik saben saham (EPS TTM)

Emergent BioSolutions (EBS) operations rely on US government biodefense contracts. The share price history on GURU.Markets reflects EPS dynamics, which stand at -458.40. Rising demand for smallpox vaccines and Narcan, coupled with debt restructuring, is driving profitability. Simultaneously, Emergent BioSolutions (EBS) is optimizing its workforce, striving to retain key manufacturing experts during a period of personnel transformation and targeted hiring.

EBS Emergent Corp: Bathi resik saben saham (EPS TTM) ing interval 11.02.2024 - 13.11.2026

Emergent Corp - rincian analitis lan metrik utama (EBS)

- rega saiki lan proyeksi nilai saham:

Bagan owah-owahan rega emergentbiosolutions.com|EBS - Target konsensus

- indikator valuasi pasar bisnis:

Kapitalisasi pasar Emergent BioSolutions Inc|EBS - Nilai Total Perusahaan

- data nilai buku modal saham:

Aset Bersih saben Saham Emergent BioSolutions|EBS - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku emergentbiosolutions.com|EBS - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Emergent BioSolutions|EBS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Emergent Bio|EBS - Utang perusahaan|Rasio utang marang aset resik Emergent BioSolutions Inc|EBS - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Emergent BioSolutions|Likuiditas darurat emergentbiosolutions.com

- data bathi bisnis lan rasio investasi:

EBS - Bathi resik perusahaan|Prakiraan bathi resik Emergent BioSolutions|EBS - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Emergent BioSolutions Inc|EBS - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Emergent BioSolutions Inc|EBS - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Emergent BioSolutions|EBS - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan emergentbiosolutions.com|EBS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Emergent BioSolutions

Analisis wiwitan perusahaan:emergentbiosolutions.com EBS

Produk asil prodhuksi Emergent BioSolutions Inc.

The monopoly position of Emergent BioSolutions (EBS) in the US biodefense sector guarantees stable demand for vaccines regardless of market conditions. This pricing power translates directly into net profit per share dynamics. This metric measures the rolling annual rate of change in EPS, allowing for an assessment of real business efficiency without market noise. Analyzing the annual growth of EPS TTM helps investors determine the company's true growth momentum relative to sector peers.

Analisis pesaing Emergent BioSolutions